Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 23% ± 7% | |
lung | 8 studies | 24% ± 7% | |
brain | 5 studies | 21% ± 7% | |
lymph node | 4 studies | 23% ± 10% | |
intestine | 4 studies | 23% ± 10% | |
pancreas | 3 studies | 28% ± 10% | |
kidney | 3 studies | 24% ± 5% | |
liver | 3 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5719.72 | 1445 / 1445 | 100% | 64.78 | 183 / 183 |
liver | 100% | 7355.39 | 226 / 226 | 100% | 70.50 | 406 / 406 |
ovary | 100% | 6907.00 | 180 / 180 | 100% | 90.23 | 430 / 430 |
pancreas | 100% | 3736.61 | 328 / 328 | 100% | 68.74 | 178 / 178 |
stomach | 100% | 4836.77 | 359 / 359 | 100% | 86.28 | 286 / 286 |
thymus | 100% | 7538.63 | 653 / 653 | 100% | 65.43 | 605 / 605 |
uterus | 100% | 6823.86 | 170 / 170 | 100% | 74.48 | 459 / 459 |
skin | 100% | 5289.15 | 1808 / 1809 | 100% | 78.12 | 472 / 472 |
kidney | 100% | 6817.35 | 89 / 89 | 100% | 76.21 | 900 / 901 |
brain | 100% | 4844.14 | 2637 / 2642 | 100% | 60.48 | 705 / 705 |
intestine | 100% | 6532.70 | 966 / 966 | 100% | 101.41 | 526 / 527 |
bladder | 100% | 6271.10 | 21 / 21 | 100% | 88.74 | 503 / 504 |
prostate | 100% | 8527.92 | 245 / 245 | 100% | 72.67 | 500 / 502 |
lung | 100% | 7129.39 | 578 / 578 | 100% | 66.77 | 1150 / 1155 |
adrenal gland | 100% | 8439.02 | 258 / 258 | 100% | 60.87 | 229 / 230 |
breast | 100% | 5417.91 | 459 / 459 | 99% | 62.70 | 1106 / 1118 |
adipose | 100% | 5142.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 72.87 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 79.85 | 29 / 29 |
spleen | 100% | 9688.12 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 62.11 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.73 | 1 / 1 |
blood vessel | 100% | 4855.65 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 3783.72 | 859 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 7162.61 | 920 / 929 | 0% | 0 | 0 / 0 |
muscle | 99% | 3046.69 | 795 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0060546 | Biological process | negative regulation of necroptotic process |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0042742 | Biological process | defense response to bacterium |
GO_0009893 | Biological process | positive regulation of metabolic process |
GO_0097039 | Biological process | protein linear polyubiquitination |
GO_0071797 | Cellular component | LUBAC complex |
GO_0005829 | Cellular component | cytosol |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_1990757 | Molecular function | ubiquitin ligase activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0043130 | Molecular function | ubiquitin binding |
Gene name | RBCK1 |
Protein name | HCG2019817, isoform CRA_d (RANBP2-type and C3HC4-type zinc finger containing 1) RANBP2-type and C3HC4-type zinc finger containing 1 RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3) RANBP2-type and C3HC4-type zinc finger containing 1 (cDNA FLJ60704, highly similar to RanBP-type and C3HC4-type zincfinger-containing protein 1) |
Synonyms | hCG_2019817 UBCE7IP3 XAP3 XAP4 C20orf18 RNF54 |
Description | FUNCTION: E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, such as UBE2L3/UBCM4, and then transfers it to substrates . Functions as an E3 ligase for oxidized IREB2 and both heme and oxygen are necessary for IREB2 ubiquitination . Promotes ubiquitination of TAB2 and IRF3 and their degradation by the proteasome . Component of the LUBAC complex which conjugates linear ('Met-1'-linked) polyubiquitin chains to substrates and plays a key role in NF-kappa-B activation and regulation of inflammation . LUBAC conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in activation of the canonical NF-kappa-B and the JNK signaling pathways . Linear ubiquitination mediated by the LUBAC complex interferes with TNF-induced cell death and thereby prevents inflammation . LUBAC is recruited to the TNF-R1 signaling complex (TNF-RSC) following polyubiquitination of TNF-RSC components by BIRC2 and/or BIRC3 and to conjugate linear polyubiquitin to IKBKG and possibly other components contributing to the stability of the complex . The LUBAC complex is also involved in innate immunity by conjugating linear polyubiquitin chains at the surface of bacteria invading the cytosol to form the ubiquitin coat surrounding bacteria . LUBAC is not able to initiate formation of the bacterial ubiquitin coat, and can only promote formation of linear polyubiquitins on pre-existing ubiquitin . The bacterial ubiquitin coat acts as an 'eat-me' signal for xenophagy and promotes NF-kappa-B activation . Together with OTULIN, the LUBAC complex regulates the canonical Wnt signaling during angiogenesis . Binds polyubiquitin of different linkage types . . |
Accessions | ENST00000441733.5 ENST00000411647.5 A0A8V8TLQ1 ENST00000400245.3 A6PVJ6 ENST00000475269.5 A0A8V8TMQ4 Q5JWR1 ENST00000400247.3 ENST00000415942.5 ENST00000697804.1 ENST00000697805.1 A0A8V8TMZ2 Q9BYM8 ENST00000353660.7 [Q9BYM8-3] A6PVJ7 H0Y4S7 A6PVJ5 ENST00000382214.7 B4DML5 G3XAG9 ENST00000414880.1 ENST00000382181.2 [Q9BYM8-4] ENST00000356286.10 [Q9BYM8-1] |